Literature DB >> 1518109

Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study.

C J Berger1, J M Murabito, J C Evans, K M Anderson, D Levy.   

Abstract

OBJECTIVE: To compare the short- and long-term prognosis following a first Q-wave or non-Q-wave myocardial infarction.
DESIGN: Cohort study with a mean follow-up period of 5.1 +/- 4.9 years.
SETTING: Population-based. PARTICIPANTS: Framingham (Mass) Heart Study subjects with an initial recognized myocardial infarction during a 17-year period were studied, including 227 men and 136 women with a mean age of 67.2 years. Seventy-seven percent of first infarctions were Q-wave infarctions and 23% were non-Q-wave infarctions. MAIN OUTCOME MEASURES: Reinfarction and death from coronary heart disease.
RESULTS: During the follow-up period, subjects with non-Q-wave infarctions had a significantly higher rate of reinfarction than subjects in the Q-wave group (P = .02 for the entire follow-up). The 10-year reinfarction rates were 44.8% vs 27.4%. When analyzed separately by age and sex, differences in reinfarction rates were only noted in men and in those under the age of 65 years. There were no differences in coronary heart disease death rates based on Q-wave status, even when examined separately by age and sex. Multivariate analysis revealed a 1.8-fold higher risk of reinfarction in the non-Q-wave group (95% confidence interval, 1.1 to 3.1), and also demonstrated that baseline hypertension was an independent risk factor for predicting reinfarction (relative risk, 1.8; 95% confidence interval, 1.1 to 3.2). There were no differences in the rates of sudden death or all-cause mortality following the two types of myocardial infarction. Additionally, subjects with a first Q-wave infarction had a higher rate of subsequent congestive heart failure, while those with non-Q-wave infarctions had a significantly higher rate of coronary insufficiency (unstable angina with transient ST-T wave abnormalities).
CONCLUSIONS: These results confirm and extend findings from prior studies that have identified patients with first non-Q-wave myocardial infarctions as potentially unstable, with greater subsequent morbidity and similar mortality to their counterparts with Q-wave infarctions.

Entities:  

Mesh:

Year:  1992        PMID: 1518109     DOI: 10.1001/jama.268.12.1545

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Necessity of using intermediate outcome to proxy long term effects. The example of thrombolytics.

Authors:  J S Schwartz
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

Review 2.  Chest pain: coronary CT in the ER.

Authors:  Erica Maffei; Sara Seitun; Andrea I Guaricci; Filippo Cademartiri
Journal:  Br J Radiol       Date:  2016-02-11       Impact factor: 3.039

Review 3.  Management of acute myocardial infarction in the elderly.

Authors:  D E Forman; M W Rich
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

4.  Quantitation of infarct size in patients with chronic coronary artery disease using rest-redistribution Tl-201 myocardial perfusion SPECT: correlation with contrast-enhanced cardiac magnetic resonance.

Authors:  David S Fieno; Louise E J Thomson; Piotr Slomka; Aiden Abidov; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 5.  Recent advances in the management of unstable angina and non-Q-wave myocardial infarction.

Authors:  R P Steeds; K S Channer
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 6.  Global burden of Sudden Cardiac Death and insights from India.

Authors:  B Hygriv Rao
Journal:  Indian Heart J       Date:  2013-12-25

7.  The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation.

Authors:  Laura Panattoni; Paul M Brown; Braden Te Ao; Mark Webster; Patrick Gladding
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

8.  Changing the diagnostic criteria for myocardial infarction in patients with a suspected heart attack affects the measurement of 30 day mortality but not long term survival.

Authors:  C Packham; D Gray; C Weston; A Large; P Silcocks; J Hampton
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

9.  Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Authors:  Jeffrey E Olgin; Mark J Pletcher; Eric Vittinghoff; Jerzy Wranicz; Rajesh Malik; Daniel P Morin; Steven Zweibel; Alfred E Buxton; Claude S Elayi; Eugene H Chung; Eric Rashba; Martin Borggrefe; Trisha F Hue; Carol Maguire; Feng Lin; Joel A Simon; Stephen Hulley; Byron K Lee
Journal:  N Engl J Med       Date:  2018-09-27       Impact factor: 91.245

10.  Sudden death after myocardial infarction.

Authors:  A Selcuk Adabag; Terry M Therneau; Bernard J Gersh; Susan A Weston; Véronique L Roger
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.